PelvicSense Program for Vulvodynia
Trial Summary
What is the purpose of this trial?
This study will examine the effectiveness of the PelvicSense 3-month online program on pain and other outcomes in those with provoked vestibulodynia. This study is prospective in nature and will involve several assessment points: baseline, immediately post-treatment (at the end of the 3 month program), and 3-month follow up. All aspects of the study will be conducted remotely (e.g., online, email, video calls), and participants will be at least 18 years of age, fluent in English, and experience pain due to provoked vestibulodynia for at least 3 months with a physician diagnosis. Participants are expected to continue their treatment as usual and this information will be documented throughout the study.
Will I have to stop taking my current medications?
No, you will not have to stop taking your current medications. Participants are expected to continue their treatment as usual during the study.
How is the PelvicSense treatment for vulvodynia different from other treatments?
Research Team
Caroline Pukall, PhD
Principal Investigator
Queen's University
Eligibility Criteria
This trial is for adults over 18 who speak English and have been diagnosed with provoked vestibulodynia, a condition causing pain in the vulvar region, for at least three months. Participants will engage in an online program called PelvicSense and must continue their usual treatment during the study.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in the PelvicSense 3-month online program focusing on physiotherapy techniques
Follow-up
Participants are monitored for pain and sexual outcomes 3 months after the end of the program
Treatment Details
Interventions
- PelvicSense(R)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Dr. Caroline Pukall
Lead Sponsor
Dr. Caroline Pukall
Lead Sponsor
Queen's University
Lead Sponsor